APO Research
Talk to an analyst

APO RESEARCH · REPORT

Candesartan and Hydrochlorothiazide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Candesartan and Hydrochlorothiazide Industry Growth and Trends Forecast to 2032

20 December 202596 pages

Choose your research edition.

Industry ResearchCandesartan and Hydrochlorothiazide Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Candesartan and Hydrochlorothiazide Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Candesartan and Hydrochlorothiazide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Candesartan and Hydrochlorothiazide Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Candesartan and Hydrochlorothiazide Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Candesartan and Hydrochlorothiazide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Candesartan and Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Candesartan and Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Candesartan and Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Candesartan and Hydrochlorothiazide include ANI Pharmaceuticals, Dr. Reddy's Laboratories, MACLEODS, Prinston Pharmaceutical, Zydus Pharmaceuticals, AstraZeneca, Mylan and TEVA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Candesartan and Hydrochlorothiazide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Candesartan and Hydrochlorothiazide market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Candesartan and Hydrochlorothiazide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Candesartan and Hydrochlorothiazide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Candesartan and Hydrochlorothiazide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Candesartan and Hydrochlorothiazide Market by Company

ANI Pharmaceuticals

Dr. Reddy's Laboratories

MACLEODS

Prinston Pharmaceutical

Zydus Pharmaceuticals

AstraZeneca

Mylan

TEVA

Candesartan and Hydrochlorothiazide Segment by Type

16/12.5

32/12.5

32/25

Candesartan and Hydrochlorothiazide Segment by Application

Adults

Geriatric

Candesartan and Hydrochlorothiazide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Candesartan and Hydrochlorothiazide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Candesartan and Hydrochlorothiazide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Candesartan and Hydrochlorothiazide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Candesartan and Hydrochlorothiazide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Candesartan and Hydrochlorothiazide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 16/12.5 Table 2. Major Company of 32/12.5 Table 3. Major Company of 32/25 Table 4. Global Candesartan and Hydrochlorothiazide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (W Units) Table 6. Global Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Type (2021-2026) Table 7. Global Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (US$ Million) Table 8. Global Candesartan and Hydrochlorothiazide Sales Market Share in Value by Type (2021-2026) Table 9. Global Candesartan and Hydrochlorothiazide Price by Type (2021-2026) & (US$/Unit) Table 10. Global Candesartan and Hydrochlorothiazide Sales by Type (2027-2032) & (W Units) Table 11. Global Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Type (2027-2032) Table 12. Global Candesartan and Hydrochlorothiazide Sales by Type (2027-2032) & (US$ Million) Table 13. Global Candesartan and Hydrochlorothiazide Sales Market Share in Value by Type (2027-2032) Table 14. Global Candesartan and Hydrochlorothiazide Price by Type (2027-2032) & (US$/Unit) Table 15. North America Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (W Units) Table 16. North America Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (W Units) Table 18. Europe Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (W Units) Table 22. Latin America Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Type (2021-2026) & (US$ Million) Table 25. Candesartan and Hydrochlorothiazide Industry Trends Table 26. Candesartan and Hydrochlorothiazide Industry Drivers Table 27. Candesartan and Hydrochlorothiazide Industry Opportunities and Challenges Table 28. Candesartan and Hydrochlorothiazide Industry Restraints Table 29. Global Candesartan and Hydrochlorothiazide Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Company (2021-2026) Table 31. Global Candesartan and Hydrochlorothiazide Sales by Company (2021-2026) & (W Units) Table 32. Global Candesartan and Hydrochlorothiazide Sales Share by Company (2021-2026) Table 33. Global Candesartan and Hydrochlorothiazide Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Candesartan and Hydrochlorothiazide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Candesartan and Hydrochlorothiazide Major Company Production Sites and Headquarters Table 36. Global Candesartan and Hydrochlorothiazide Company, Product Type & Application Table 37. Global Candesartan and Hydrochlorothiazide Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Candesartan and Hydrochlorothiazide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Candesartan and Hydrochlorothiazide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Candesartan and Hydrochlorothiazide Sales by Region (2021-2026) & (W Units) Table 42. Global Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Region (2021-2026) Table 43. Global Candesartan and Hydrochlorothiazide Sales by Region (2021-2026) & (US$ Million) Table 44. Global Candesartan and Hydrochlorothiazide Sales Market Share in Value by Region (2021-2026) Table 45. Global Candesartan and Hydrochlorothiazide Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Candesartan and Hydrochlorothiazide Sales by Region (2027-2032) & (W Units) Table 47. Global Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Region (2027-2032) Table 48. Global Candesartan and Hydrochlorothiazide Sales by Region (2027-2032) & (US$ Million) Table 49. Global Candesartan and Hydrochlorothiazide Sales Market Share in Value by Region (2027-2032) Table 50. Global Candesartan and Hydrochlorothiazide Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Candesartan and Hydrochlorothiazide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (W Units) Table 53. Global Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Application (2021-2026) Table 54. Global Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (US$ Million) Table 55. Global Candesartan and Hydrochlorothiazide Sales Market Share in Value by Application (2021-2026) Table 56. Global Candesartan and Hydrochlorothiazide Price by Application (2021-2026) & (US$/Unit) Table 57. Global Candesartan and Hydrochlorothiazide Sales by Application (2027-2032) & (W Units) Table 58. Global Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Application (2027-2032) Table 59. Global Candesartan and Hydrochlorothiazide Sales by Application (2027-2032) & (US$ Million) Table 60. Global Candesartan and Hydrochlorothiazide Sales Market Share in Value by Application (2027-2032) Table 61. Global Candesartan and Hydrochlorothiazide Price by Application (2027-2032) & (US$/Unit) Table 62. North America Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (W Units) Table 63. North America Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (W Units) Table 65. Europe Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (W Units) Table 69. Latin America Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Application (2021-2026) & (US$ Million) Table 72. ANI Pharmaceuticals Company Information Table 73. ANI Pharmaceuticals Business Overview Table 74. ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolio Table 76. ANI Pharmaceuticals Recent Development Table 77. Dr. Reddy's Laboratories Company Information Table 78. Dr. Reddy's Laboratories Business Overview Table 79. Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product Portfolio Table 81. Dr. Reddy's Laboratories Recent Development Table 82. MACLEODS Company Information Table 83. MACLEODS Business Overview Table 84. MACLEODS Candesartan and Hydrochlorothiazide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. MACLEODS Candesartan and Hydrochlorothiazide Product Portfolio Table 86. MACLEODS Recent Development Table 87. Prinston Pharmaceutical Company Information Table 88. Prinston Pharmaceutical Business Overview Table 89. Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product Portfolio Table 91. Prinston Pharmaceutical Recent Development Table 92. Zydus Pharmaceuticals Company Information Table 93. Zydus Pharmaceuticals Business Overview Table 94. Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolio Table 96. Zydus Pharmaceuticals Recent Development Table 97. AstraZeneca Company Information Table 98. AstraZeneca Business Overview Table 99. AstraZeneca Candesartan and Hydrochlorothiazide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. AstraZeneca Candesartan and Hydrochlorothiazide Product Portfolio Table 101. AstraZeneca Recent Development Table 102. Mylan Company Information Table 103. Mylan Business Overview Table 104. Mylan Candesartan and Hydrochlorothiazide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Mylan Candesartan and Hydrochlorothiazide Product Portfolio Table 106. Mylan Recent Development Table 107. TEVA Company Information Table 108. TEVA Business Overview Table 109. TEVA Candesartan and Hydrochlorothiazide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. TEVA Candesartan and Hydrochlorothiazide Product Portfolio Table 111. TEVA Recent Development Table 112. North America Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 113. North America Candesartan and Hydrochlorothiazide Sales by Country (2021-2026) & (W Units) Table 114. North America Candesartan and Hydrochlorothiazide Sales Market Share by Country (2021-2026) Table 115. North America Candesartan and Hydrochlorothiazide Sales Forecast by Country (2027-2032) & (W Units) Table 116. North America Candesartan and Hydrochlorothiazide Sales Market Share Forecast by Country (2027-2032) Table 117. North America Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Candesartan and Hydrochlorothiazide Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Candesartan and Hydrochlorothiazide Market Share by Country (2021-2026) Table 120. North America Candesartan and Hydrochlorothiazide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Candesartan and Hydrochlorothiazide Market Share Forecast by Country (2027-2032) Table 122. Europe Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 123. Europe Candesartan and Hydrochlorothiazide Sales by Country (2021-2026) & (W Units) Table 124. Europe Candesartan and Hydrochlorothiazide Sales Market Share by Country (2021-2026) Table 125. Europe Candesartan and Hydrochlorothiazide Sales Forecast by Country (2027-2032) & (W Units) Table 126. Europe Candesartan and Hydrochlorothiazide Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Candesartan and Hydrochlorothiazide Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Candesartan and Hydrochlorothiazide Market Share by Country (2021-2026) Table 130. Europe Candesartan and Hydrochlorothiazide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Candesartan and Hydrochlorothiazide Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Candesartan and Hydrochlorothiazide Sales by Country (2021-2026) & (W Units) Table 134. Asia-Pacific Candesartan and Hydrochlorothiazide Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Candesartan and Hydrochlorothiazide Sales Forecast by Country (2027-2032) & (W Units) Table 136. Asia-Pacific Candesartan and Hydrochlorothiazide Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Candesartan and Hydrochlorothiazide Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Candesartan and Hydrochlorothiazide Market Share by Country (2021-2026) Table 140. Asia-Pacific Candesartan and Hydrochlorothiazide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Candesartan and Hydrochlorothiazide Market Share Forecast by Country (2027-2032) Table 142. Latin America Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Latin America Candesartan and Hydrochlorothiazide Sales by Country (2021-2026) & (W Units) Table 144. Latin America Candesartan and Hydrochlorothiazide Sales Market Share by Country (2021-2026) Table 145. Latin America Candesartan and Hydrochlorothiazide Sales Forecast by Country (2027-2032) & (W Units) Table 146. Latin America Candesartan and Hydrochlorothiazide Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Candesartan and Hydrochlorothiazide Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Candesartan and Hydrochlorothiazide Market Share by Country (2021-2026) Table 150. Latin America Candesartan and Hydrochlorothiazide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Candesartan and Hydrochlorothiazide Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Country (2021-2026) & (W Units) Table 154. Middle East and Africa Candesartan and Hydrochlorothiazide Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Candesartan and Hydrochlorothiazide Sales Forecast by Country (2027-2032) & (W Units) Table 156. Middle East and Africa Candesartan and Hydrochlorothiazide Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Candesartan and Hydrochlorothiazide Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Candesartan and Hydrochlorothiazide Market Share by Country (2021-2026) Table 160. Middle East and Africa Candesartan and Hydrochlorothiazide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Candesartan and Hydrochlorothiazide Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Candesartan and Hydrochlorothiazide Distributors List Table 165. Candesartan and Hydrochlorothiazide Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Candesartan and Hydrochlorothiazide Image Figure 2. Global Candesartan and Hydrochlorothiazide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Candesartan and Hydrochlorothiazide Market Size (2021-2032) & (US$ Million) Figure 4. Global Candesartan and Hydrochlorothiazide Sales (2021-2032) & (W Units) Figure 5. 16/12.5 Image Figure 6. Global 16/12.5 Sales YoY Growth (2021-2032) & (W Units) Figure 7. 32/12.5 Image Figure 8. Global 32/12.5 Sales YoY Growth (2021-2032) & (W Units) Figure 9. 32/25 Image Figure 10. Global 32/25 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Candesartan and Hydrochlorothiazide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Candesartan and Hydrochlorothiazide Market Share by Type 2025 VS 2032 Figure 13. North America Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Type in 2025 Figure 14. North America Candesartan and Hydrochlorothiazide Sales Market Share in Value by Type in 2025 Figure 15. Europe Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Type in 2025 Figure 16. Europe Candesartan and Hydrochlorothiazide Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Candesartan and Hydrochlorothiazide Sales Market Share in Value by Type in 2025 Figure 19. Latin America Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Candesartan and Hydrochlorothiazide Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Candesartan and Hydrochlorothiazide Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Candesartan and Hydrochlorothiazide Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adults Image Figure 26. Global Adults Sales YoY Growth (2021-2032) & (W Units) Figure 27. Geriatric Image Figure 28. Global Geriatric Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Candesartan and Hydrochlorothiazide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Candesartan and Hydrochlorothiazide Market Share by Application 2025 VS 2032 Figure 31. North America Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Application in 2025 Figure 32. North America Candesartan and Hydrochlorothiazide Sales Market Share in Value by Application in 2025 Figure 33. Europe Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Application in 2025 Figure 34. Europe Candesartan and Hydrochlorothiazide Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Candesartan and Hydrochlorothiazide Sales Market Share in Value by Application in 2025 Figure 37. Latin America Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Candesartan and Hydrochlorothiazide Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Candesartan and Hydrochlorothiazide Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Candesartan and Hydrochlorothiazide Sales Market Share in Value by Application in 2025 Figure 41. North America Candesartan and Hydrochlorothiazide Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Candesartan and Hydrochlorothiazide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Candesartan and Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Candesartan and Hydrochlorothiazide Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Candesartan and Hydrochlorothiazide Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Candesartan and Hydrochlorothiazide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Candesartan and Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Candesartan and Hydrochlorothiazide Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Candesartan and Hydrochlorothiazide Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Candesartan and Hydrochlorothiazide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Candesartan and Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Candesartan and Hydrochlorothiazide Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Candesartan and Hydrochlorothiazide Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Candesartan and Hydrochlorothiazide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Candesartan and Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Candesartan and Hydrochlorothiazide Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Candesartan and Hydrochlorothiazide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Candesartan and Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Candesartan and Hydrochlorothiazide Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Candesartan and Hydrochlorothiazide Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Candesartan and Hydrochlorothiazide Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 16/12.5
  • 32/12.5
  • 32/25
Applications
  • Adults
  • Geriatric
Companies covered
  • ANI Pharmaceuticals
  • Dr. Reddy's Laboratories
  • MACLEODS
  • Prinston Pharmaceutical
  • Zydus Pharmaceuticals
  • AstraZeneca
  • Mylan
  • TEVA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Candesartan and Hydrochlorothiazide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Candesartan and Hydrochlorothiazide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Candesartan and Hydrochlorothiazide Market by Type
  6. 1.3.1 16/12.5
  7. 1.3.2 32/12.5
  8. 1.3.3 32/25
  9. 1.4 Global Candesartan and Hydrochlorothiazide Market Size by Type
  10. 1.4.1 Global Candesartan and Hydrochlorothiazide Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Candesartan and Hydrochlorothiazide Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Candesartan and Hydrochlorothiazide Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Candesartan and Hydrochlorothiazide Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Candesartan and Hydrochlorothiazide Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Candesartan and Hydrochlorothiazide Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Candesartan and Hydrochlorothiazide Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Candesartan and Hydrochlorothiazide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Candesartan and Hydrochlorothiazide Industry Trends
  2. 2.2 Candesartan and Hydrochlorothiazide Industry Drivers
  3. 2.3 Candesartan and Hydrochlorothiazide Industry Opportunities and Challenges
  4. 2.4 Candesartan and Hydrochlorothiazide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Candesartan and Hydrochlorothiazide Revenue (2021-2026)
  2. 3.2 Global Top Players by Candesartan and Hydrochlorothiazide Sales (2021-2026)
  3. 3.3 Global Top Players by Candesartan and Hydrochlorothiazide Price (2021-2026)
  4. 3.4 Global Candesartan and Hydrochlorothiazide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Candesartan and Hydrochlorothiazide Major Company Production Sites & Headquarters
  6. 3.6 Global Candesartan and Hydrochlorothiazide Company, Product Type & Application
  7. 3.7 Global Candesartan and Hydrochlorothiazide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Candesartan and Hydrochlorothiazide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Candesartan and Hydrochlorothiazide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Candesartan and Hydrochlorothiazide Tier 1, Tier 2, and Tier 3
4 Candesartan and Hydrochlorothiazide Regional Status and Outlook
  1. 4.1 Global Candesartan and Hydrochlorothiazide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Candesartan and Hydrochlorothiazide Historic Market Size by Region
  3. 4.2.1 Global Candesartan and Hydrochlorothiazide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Candesartan and Hydrochlorothiazide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Candesartan and Hydrochlorothiazide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Candesartan and Hydrochlorothiazide Forecasted Market Size by Region
  7. 4.3.1 Global Candesartan and Hydrochlorothiazide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Candesartan and Hydrochlorothiazide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Candesartan and Hydrochlorothiazide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Candesartan and Hydrochlorothiazide by Application
  1. 5.1 Candesartan and Hydrochlorothiazide Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Geriatric
  4. 5.2 Global Candesartan and Hydrochlorothiazide Market Size by Application
  5. 5.2.1 Global Candesartan and Hydrochlorothiazide Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Candesartan and Hydrochlorothiazide Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Candesartan and Hydrochlorothiazide Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Candesartan and Hydrochlorothiazide Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Candesartan and Hydrochlorothiazide Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Candesartan and Hydrochlorothiazide Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Candesartan and Hydrochlorothiazide Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Candesartan and Hydrochlorothiazide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ANI Pharmaceuticals
  2. 6.1.1 ANI Pharmaceuticals Company Information
  3. 6.1.2 ANI Pharmaceuticals Business Overview
  4. 6.1.3 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolio
  6. 6.1.5 ANI Pharmaceuticals Recent Developments
  7. 6.2 Dr. Reddy's Laboratories
  8. 6.2.1 Dr. Reddy's Laboratories Company Information
  9. 6.2.2 Dr. Reddy's Laboratories Business Overview
  10. 6.2.3 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product Portfolio
  12. 6.2.5 Dr. Reddy's Laboratories Recent Developments
  13. 6.3 MACLEODS
  14. 6.3.1 MACLEODS Company Information
  15. 6.3.2 MACLEODS Business Overview
  16. 6.3.3 MACLEODS Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 MACLEODS Candesartan and Hydrochlorothiazide Product Portfolio
  18. 6.3.5 MACLEODS Recent Developments
  19. 6.4 Prinston Pharmaceutical
  20. 6.4.1 Prinston Pharmaceutical Company Information
  21. 6.4.2 Prinston Pharmaceutical Business Overview
  22. 6.4.3 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product Portfolio
  24. 6.4.5 Prinston Pharmaceutical Recent Developments
  25. 6.5 Zydus Pharmaceuticals
  26. 6.5.1 Zydus Pharmaceuticals Company Information
  27. 6.5.2 Zydus Pharmaceuticals Business Overview
  28. 6.5.3 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolio
  30. 6.5.5 Zydus Pharmaceuticals Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Candesartan and Hydrochlorothiazide Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Candesartan and Hydrochlorothiazide Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 TEVA
  44. 6.8.1 TEVA Company Information
  45. 6.8.2 TEVA Business Overview
  46. 6.8.3 TEVA Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 TEVA Candesartan and Hydrochlorothiazide Product Portfolio
  48. 6.8.5 TEVA Recent Developments
7 North America by Country
  1. 7.1 North America Candesartan and Hydrochlorothiazide Sales by Country
  2. 7.1.1 North America Candesartan and Hydrochlorothiazide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Candesartan and Hydrochlorothiazide Sales by Country (2021-2026)
  4. 7.1.3 North America Candesartan and Hydrochlorothiazide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Candesartan and Hydrochlorothiazide Market Size by Country
  6. 7.2.1 North America Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Candesartan and Hydrochlorothiazide Market Size by Country (2021-2026)
  8. 7.2.3 North America Candesartan and Hydrochlorothiazide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Candesartan and Hydrochlorothiazide Sales by Country
  2. 8.1.1 Europe Candesartan and Hydrochlorothiazide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Candesartan and Hydrochlorothiazide Sales by Country (2021-2026)
  4. 8.1.3 Europe Candesartan and Hydrochlorothiazide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Candesartan and Hydrochlorothiazide Market Size by Country
  6. 8.2.1 Europe Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Candesartan and Hydrochlorothiazide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Candesartan and Hydrochlorothiazide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Candesartan and Hydrochlorothiazide Sales by Country
  2. 9.1.1 Asia-Pacific Candesartan and Hydrochlorothiazide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Candesartan and Hydrochlorothiazide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Candesartan and Hydrochlorothiazide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Candesartan and Hydrochlorothiazide Market Size by Country
  6. 9.2.1 Asia-Pacific Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Candesartan and Hydrochlorothiazide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Candesartan and Hydrochlorothiazide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Candesartan and Hydrochlorothiazide Sales by Country
  2. 10.1.1 South America Candesartan and Hydrochlorothiazide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Candesartan and Hydrochlorothiazide Sales by Country (2021-2026)
  4. 10.1.3 South America Candesartan and Hydrochlorothiazide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Candesartan and Hydrochlorothiazide Market Size by Country
  6. 10.2.1 South America Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Candesartan and Hydrochlorothiazide Market Size by Country (2021-2026)
  8. 10.2.3 South America Candesartan and Hydrochlorothiazide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Country
  2. 11.1.1 Middle East and Africa Candesartan and Hydrochlorothiazide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Candesartan and Hydrochlorothiazide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Candesartan and Hydrochlorothiazide Market Size by Country
  6. 11.2.1 Middle East and Africa Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Candesartan and Hydrochlorothiazide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Candesartan and Hydrochlorothiazide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Candesartan and Hydrochlorothiazide Value Chain Analysis
  2. 12.1.1 Candesartan and Hydrochlorothiazide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Candesartan and Hydrochlorothiazide Production Mode & Process
  7. 12.2 Candesartan and Hydrochlorothiazide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Candesartan and Hydrochlorothiazide Distributors
  10. 12.2.3 Candesartan and Hydrochlorothiazide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst